9IUO
 
 | | Human MTHFD1 in complex with compound 16d | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-methyl-phenyl]carbonylamino]pentanedioic acid, C-1-tetrahydrofolate synthase, cytoplasmic, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-22 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.09 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ISC
 | | Human MTHFD2 in complex with compound 16a | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]-4-(1~{H}-1,2,3,4-tetrazol-5-yl)butanoic acid, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-17 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.54 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9IT3
 | | Human MTHFD2 in complex with compound 16e | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]pentanedioic acid, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-19 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.06 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9IS9
 | | human MTHFD2 in complex with LY374571 | | Descriptor: | (2S)-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1H-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]pentanedioic acid, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-17 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.12 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ITA
 | | Human MTHFD2 in complex with compound 16d | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-methyl-phenyl]carbonylamino]pentanedioic acid, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-19 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ISL
 | | Human MTHFD1 in complex with compound 16e | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]pentanedioic acid, C-1-tetrahydrofolate synthase, cytoplasmic, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-18 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.06 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ISR
 | | Human MTHFD1 in complex with compound 16g | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]-4-(1~{H}-1,2,3,4-tetrazol-5-yl)butanoic acid, C-1-tetrahydrofolate synthase, cytoplasmic, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-18 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ITD
 | | Human MTHFD1 in complex with compound 16a | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]-4-(1~{H}-1,2,3,4-tetrazol-5-yl)butanoic acid, C-1-tetrahydrofolate synthase, cytoplasmic, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-19 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.28 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9IT6
 | | Human MTHFD2 in complex with compound 16g | | Descriptor: | (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]-4-(1~{H}-1,2,3,4-tetrazol-5-yl)butanoic acid, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-19 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (2.04 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
9ISE
 | | Human MTHFD1 in complex with LY374571 | | Descriptor: | (2S)-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1H-pyrimidin-5-yl]carbamoylamino]phenyl]carbonylamino]pentanedioic acid, C-1-tetrahydrofolate synthase, cytoplasmic, ... | | Authors: | Lee, L.C, Wu, S.Y. | | Deposit date: | 2024-07-17 | | Release date: | 2025-01-01 | | Method: | X-RAY DIFFRACTION (1.99 Å) | | Cite: | Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization.
J.Med.Chem., 67, 2024
|
|
